The summit was organised by MCH Group in collaboration with the European start-up festival Bits & Pretzels. Designed as a platform at the crossroads of health, technology and investment, the event combined keynote presentations, panel discussions, investor sessions and start-up showcases. More than 120 emerging companies presented new ideas and solutions, while sessions explored topics including digital health platforms, artificial intelligence in clinical decision-making and new models of patient care.
The programme also reflected a growing recognition that healthcare innovation increasingly sits at the convergence of multiple disciplines. Discussions addressed regulatory frameworks, the ethical implications of digital technologies, and the challenge of translating research breakthroughs into scalable solutions. High-profile speakers, including Amal Clooney and Dr. Anthony Fauci, featured figures from medicine, technology and public policy, highlighting the summit’s ambition to position itself as a global forum for dialogue around health system transformation.
A Platform for an Evolving Industry
The launch of the summit reflects broader structural changes in the healthcare sector. Advances in artificial intelligence, data analytics and digital platforms are rapidly transforming how care is delivered, monitored and financed. At the same time, venture capital investment and start-up activity in health technology have grown significantly over the past decade, creating new opportunities – and new challenges – for healthcare systems.
Events like this increasingly function as meeting points for actors that traditionally operated in separate spheres: pharmaceutical companies, digital start-ups, hospital systems, academic researchers and investors. By bringing these groups together, the summit aims to accelerate collaboration and shorten the pathway between innovation and implementation.
According to organisers, the strong turnout for the first edition underscores the demand for a dedicated international forum focused on the technological transformation of healthcare. “The summit has already established itself as an important platform for exchange and collaboration,” noted Roman Imgrüth, CEO of Exhibitions & Events at MCH Group.
Why Basel?
The choice of Basel as host city just made sense. For decades, the Swiss city has been one of Europe’s most concentrated life sciences hubs, home to global pharmaceutical companies, cutting-edge research institutes and a dense network of biotech and health technology firms.
The region hosts multinational pharmaceutical giants such as Novartis and Roche alongside a growing ecosystem of biotech start-ups and digital health innovators. Together, these organisations form what is often described as a “life sciences supercluster,” combining research, clinical development and commercial activity within a relatively compact geographic area.
The academic environment further reinforces this ecosystem. Institutions such as the University of Basel and research centres including the Biozentrum, University of Basel, ETH Zurich D-BSSE and University of Applied Sciences Northwestern Switzerland contribute to a steady pipeline of scientific talent and interdisciplinary collaboration. The Biozentrum alone hosts dozens of research groups working on molecular life sciences, with scientists from more than 40 countries.
In this context, hosting an event dedicated to health technology innovation reflects the city’s broader identity as a hub where scientific research, industry and entrepreneurship converge. Basel’s ecosystem allows conference discussions to extend beyond theoretical debate and connect directly with laboratories, hospitals and companies actively shaping the future of healthcare.
The Role of Place in Knowledge Exchange
For international conferences, this kind of ecosystem matters. Increasingly, association and industry events seek destinations that offer more than meeting space – cities where local expertise, research institutions and industry partners can actively contribute to the programme.
During the summit, participants were offered opportunities to explore the region’s life sciences landscape and to discover Basel’s cultural gems through site visits, workshops and guided city tours organised in collaboration with Basel Tourism under the “Basel Unlocked” programme. Delegates were given the opportunity to explore the Basel old town or to visit companies including Roche and Novartis, as well as local manufacturers and research institutions, gaining direct insight into the ecosystem that underpins the city’s global reputation in pharmaceuticals and biotech.
More info on how Basel can help you organise conferences: www.messe-basel.com / www.basel.com/meeting
More info on Switzerland as a convention destination: myriam.winnepenninckx@switzerland.com / www.MySwitzerland.com/meetings
This type of knowledge exchange aligns with a broader shift in the meetings industry. Conferences increasingly aim to create long-term value for participants by connecting them with the host destination’s intellectual capital. In cities like Basel, these connections can occur organically.
The strong turnout of the first edition of health.tech | global summit suggests that the intersection of health and technology will remain a central theme in global scientific and business discussions for years to come. The next edition is already scheduled to return to Basel in March 2027, signalling the organisers’ intention to establish the event as a recurring platform for dialogue around healthcare transformation.
For Basel, the event reinforces a longstanding identity as a meeting point for trade, science and culture.